Jacobs Levy Equity Management, Inc Merck & Co., Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,926,675 shares of MRK stock, worth $190 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
1,926,675
Previous 1,278,793
50.66%
Holding current value
$190 Million
Previous $158 Million
38.2%
% of portfolio
0.89%
Previous 0.68%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,814Shares Held
1.88BCall Options Held
14.6MPut Options Held
13.2M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.46 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.82 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...